Clinical Trials Logo

Mixed Guttate/Plaque Psoriasis clinical trials

View clinical trials related to Mixed Guttate/Plaque Psoriasis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04123795 Recruiting - Clinical trials for Moderate Chronic Plaque Psoriasis

A Study to Evaluate the Efficacy, Safety, and Drug Concentration of Certolizumab Pegol (CZP) in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis (PSO)

CIMcare
Start date: January 21, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to demonstrate the efficacy and safety of certolizumab pegol in the treatment of moderate to severe chronic plaque psoriasis in study participants aged 6 to 11 and 12 to 17 years.